Tech Company Financing Transactions
Abeona Therapeutics Funding Round
Abeona Therapeutics, based in Cleveland, secured $3.6 million from Team Sanfilippo and private investors.
Transaction Overview
Company Name
Announced On
11/10/2014
Transaction Type
Venture Equity
Venture Equity
Venture Equity
Amount
$3,612,500
Round
Undisclosed
Investors
Team Sanfilippo (Cara O'Neill)
Proceeds Purpose
The company intends to use the funds to complete preclinical development of therapies for children with Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III), a rare terminal genetic disorder that results in death in children before they reach their mid-teens.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10000 Cedar Ave.
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Not Recorded
Overview
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
João Siffert
Chief Financial Officer
Edward Carr
Chief Financial Officer
Christine Silverstein
Chief Medical Officer
Juan Ruiz
President
Timothy Miller
VP - Bus. Development
Max Colao
VP - General Counsel
Edward Sturchio
Browse more venture capital transactions:
Prev: 11/10/2014: Ambiq Micro venture capital transaction
Next: 11/10/2014: Prositions venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs